Company Snapshot: KG  Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


King Pharmaceuticals to Present At Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference

    BRISTOL, Tenn., Jan. 30 /PRNewswire-FirstCall/ -- King Pharmaceuticals,
Inc. (NYSE: KG) announced that a live audio webcast of its presentation
scheduled for Tuesday, February 3, 2004, at 3:35 p.m., E.S.T., at the Merrill
Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference at The
Grand Hyatt Hotel in New York, New York, may be accessed via the internet.
The URL for the webcast will be http://w.on24.com/r.htm?e=4522&k=
700C58611871254FBE8D8C5F2E2C7642&s=29&presenter=kingpharmac.  This link will
allow any visitor to the website access to King's audio presentation.
Listeners should go to the site at least 15 minutes prior to this event to
register and download and install any necessary software.  Within a
twenty-four hour period from the live webcast, a replay of the audio webcast
may be accessed for 14 days after the event at the same URL.
    King, headquartered in Bristol, Tennessee, is a vertically integrated
branded pharmaceutical company. King, an S&P 500 Index company, seeks to
capitalize on opportunities in the pharmaceutical industry through the
development, including through in-licensing arrangements and acquisitions, of
novel branded prescription pharmaceutical products in attractive markets and
the strategic acquisition of branded products that can benefit from focused
promotion and marketing and product life-cycle management.


SOURCE King Pharmaceuticals, Inc.




Back to Topback to top

Related links:
  • http://www.kingpharm.com
    Company News On-Call:
  • http://www.prnewswire.com/comp/120319.html
    CONTACT:
    James E. Green, Executive Vice President,
    Corporate Affairs of King Pharmaceuticals, Inc., +1-423-989-8125